Real-world efficacy and safety of donafenib-based therapies in patients with unresectable hepatocellular carcinoma: A retrospective study.

被引：0
|
作者：
Shang, Changzhen [1 ]
Luo, Xuan [1 ]
Zhong, Jinyi [1 ]
Zhang, Jianlong [1 ]
Li, Huilong [1 ]
Tan, Wenliang [1 ]
Lei, Zhang [1 ]
Chen, Yajin [1 ]
机构：
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Hepatobiliary Surg, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16169
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of immunotherapy in patients with liver metastases in patients with esophageal cancer: A retrospective, real-world study.
    Ren, Tiejun
    Wang, Dingyi
    Gu, Jinjin
    Zhao, Lijuan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] Initial Experience With Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma: A Real-world Retrospective Study
    Takeda, Soichi
    Namisaki, Tadashi
    Tsuji, Yuki
    Fujimoto, Yuki
    Murata, Koji
    Enomoto, Masahide
    Fujinaga, Yukihisa
    Nishimura, Norihisa
    Kitagawa, Koh
    Takaya, Hiroaki
    Kaji, Kosuke
    Inoue, Takashi
    Kawaratani, Hideto
    Akahane, Takemi
    Mitoro, Akira
    Yoshiji, Hitoshi
    ANTICANCER RESEARCH, 2022, 42 (11) : 5465 - 5473
  • [33] Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study
    Lingzhan Meng
    Hu Li
    Yingjie Ji
    Peng Yu
    Zizheng Wang
    Li Cao
    Bin Shi
    Yanling Shao
    Jin Yan
    Yinjie Gao
    Zhenyu Zhu
    Cancer Immunology, Immunotherapy, 74 (1)
  • [34] Efficacy and safety of anlotinib with PD-1 inhibitors in the treatment of advanced hepatocellular carcinoma: A real-world study.
    Chen, Kehe
    Huang, Xianshi
    Yu, Lei
    Lu, Jianxun
    Huang, Fei
    Wang, Zhiguang
    Wei, Yan
    Hou, Encun
    Luo, Min
    Huang, Shiqing
    Hu, Hongbo
    Ou, Mei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 583 - 583
  • [35] Real-world dosing of regorafenib in patients with unresectable hepatocellular carcinoma (uHCC): Final analysis of the prospective, observational REFINE study.
    Finn, Richard S.
    Merle, Philippe
    Ikeda, Masafumi
    Klumpen, Heinz-Josef
    Masi, Gianluca
    Granito, Alessandro
    Lim, Ho Yeong
    Kudo, Masatoshi
    Qin, Shukui
    Gerolami, Rene
    Huang, Yi-Hsiang
    Kim, Do Young
    Pinter, Matthias
    Kato, Naoya
    Kurosaki, Masayuki
    Numata, Kazushi
    Khan, Javeed
    Ozgurdal, Kirhan
    Kim, Yoon Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 518 - 518
  • [36] The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey
    Akyildiz, Arif
    Guven, Deniz Can
    Ozluk, Ahmet Anil
    Ismayilov, Rashad
    Mutlu, Emel
    Unal, Olcun Umit
    Yildiz, Ibrahim
    Iriagac, Yakup
    Turhal, Serdar
    Akbas, Sinem
    Bayram, Ertugrul
    Telli, Tugba Akin
    Turkoz, Fatma Paksoy
    Ozcelik, Melike
    Erciyestepe, Mert
    Selvi, Oguzhan
    Gulbagci, Burcu
    Erturk, Ismail
    Isleyen, Zehra Sucuoglu
    Kahraman, Seda
    Akdag, Mutianur Ozkorkmaz
    Hamitoglu, Buket
    Unek, Ilkay Tugba
    Unal, Caglar
    Hacibekiroglu, Ilhan
    Arslan, Cagatay
    Azizy, Abdulmunir
    Helvaci, Kaan
    Demirci, Umut
    Dizdar, Omer
    Basaran, Mert
    Goker, Erdem
    Sendur, Mehmet Ali
    Yalcin, Suayib
    MEDICINE, 2023, 102 (45) : E35950
  • [37] Safety and efficacy of atezolizumab and bevacizumab delivered through a hepatology clinic for patients with unresectable hepatocellular carcinoma: Results from an Australian real-world study
    Kurup, R.
    Subhaharan, D.
    Gaggin, B.
    Wickremeratne, T.
    Sloss, A.
    Mitchell, J.
    Gupta, R.
    O'Beirne, J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 77 - 77
  • [38] Efficacy and safety of hepatic arterial infusion chemotherapy combined with donafenib in the treatment of unresectable hepatocellular carcinoma
    Wan, Tao
    Gan, Xueqin
    Xiong, Weijie
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024,
  • [39] Lenvatinib plus pembrolizumab versus lenvatinib in patients with unresectable hepatocellular carcinoma: A real world study.
    Lee, I-Cheng
    Wu, Chi-Jung
    Chen, San-Chi
    Chao, Yee
    Huang, Yi-Hsiang
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [40] Efficacy and Safety of Apatinib in Advanced Hepatocellular Carcinoma: A Multicenter Real World Retrospective Study
    Zheng, Zhuangzhuang
    Liu, Zijing
    Zhang, Haifeng
    Guo, Xiao
    Jia, Xiaojing
    Wang, Jianfeng
    Meng, Lingbin
    Xin, Ying
    Jiang, Xin
    FRONTIERS IN PHARMACOLOGY, 2022, 13
12345